Interestingly, miR-424 and miR-320a that directly target the 3′UTR of the ABL gene are under-expressed in CML and miR-320a is also downregulated in CML cancer stem cells [60, 61]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.